Vulvar cancer, version 1.2017: Clinical Practice Guidelines in Oncology Journal Article

Authors: Koh, W. J.; Greer, B. E.; Abu-Rustum, N. R.; Campos, S. M.; Cho, K. R.; Chon, H. S.; Chu, C.; Cohn, D.; Crispens, M. A.; Dizon, D. S.; Dorigo, O.; Eifel, P. J.; Fisher, C. M.; Frederick, P.; Gaffney, D. K.; Han, E.; Higgins, S.; Huh, W. K.; Lurain, J. R. 3rd; Mariani, A.; Mutch, D.; Nagel, C.; Nekhlyudov, L.; Fader, A. N.; Remmenga, S. W.; Reynolds, R. K.; Tillmanns, T.; Ueda, S.; Valea, F. A.; Wyse, E.; Yashar, C. M.; McMillian, N.; Scavone, J.
Article Title: Vulvar cancer, version 1.2017: Clinical Practice Guidelines in Oncology
Abstract: Vulvar cancer is a rare gynecologic malignancy.Ninety percent of vulvar cancers are predominantly squamous cell carcinomas (SCCs), which can arise through human papilloma virus (HPV)-dependent and HPV-independent pathways. The NCCN Vulvar Cancer panel is an interdisciplinary group of representatives from NCCN Member Institutions consisting of specialists in gynecological oncology, medical oncology, radiation oncology, and pathology. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Vulvar Cancer provide an evidence- and consensus-based approach for the management of patients with vulvar SCC. This manuscript discusses the recommendations outlined in the NCCN Guidelines for diagnosis, staging, treatment, and follow-up.
Keywords: metastases; prognostic-factors; positron-emission-tomography; phase-ii trial; squamous-cell carcinoma; lymph-node; radiation-therapy; united-states; locally advanced-carcinoma; inguinofemoral lymphadenectomy; superficial inguinal lymphadenectomy
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 15
Issue: 1
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2017-01-01
Start Page: 92
End Page: 120
Language: English
ACCESSION: WOS:000392045900008
PUBMED: 28040721
DOI: 10.6004/jnccn.2017.0008
Notes: Review -- Source: Wos
Citation Impact
MSK Authors
Related MSK Work